Engineering NK-92 Cell by Upregulating CXCR2 and IL-2 Via CRISPR-Cas9 Improves Its Antitumor Effects As Cellular Immunotherapy for Human Colon Cancer.
Journal of Interferon & Cytokine Research（2021）
Key words
adoptive cell immunotherapy,NK,CXCR2,IL-2,CRISPR-Cas9,colon cancer
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined